- cafead   Jan 12, 2024 at 11:42: AM
via By picking up Carmot and its three lead molecules — which are all GLP-1 analogues and being tested in advanced stages of clinical trials — Roche is on par with Novo Nordisk and Eli Lilly, the current leaders in the obesity drug space, according to analytics company GlobalData.
article source
article source